Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash from Investing Activities (2016 - 2017)

Historic Cash from Investing Activities for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $1.1 million.

  • Tenax Therapeutics' Cash from Investing Activities fell 9092.81% to $1.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.7 million, marking a year-over-year decrease of 8311.61%. This contributed to the annual value of $3000.0 for FY2023, which is 22914.33% up from last year.
  • According to the latest figures from Q4 2017, Tenax Therapeutics' Cash from Investing Activities is $1.1 million, which was down 9092.81% from $756129.0 recorded in Q3 2017.
  • Over the past 5 years, Tenax Therapeutics' Cash from Investing Activities peaked at $12.4 million during Q4 2016, and registered a low of -$34.6 million during Q3 2014.
  • For the 5-year period, Tenax Therapeutics' Cash from Investing Activities averaged around -$1.7 million, with its median value being -$171818.5 (2013).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 10418566.17% in 2014, then skyrocketed by 9889.85% in 2015.
  • Over the past 5 years, Tenax Therapeutics' Cash from Investing Activities (Quarter) stood at -$3.7 million in 2013, then fell by 25.07% to -$4.7 million in 2014, then soared by 91.85% to -$380876.0 in 2015, then surged by 3350.11% to $12.4 million in 2016, then plummeted by 90.93% to $1.1 million in 2017.
  • Its Cash from Investing Activities was $1.1 million in Q4 2017, compared to $756129.0 in Q3 2017 and $800501.0 in Q2 2017.